Oragenics, Inc. Receives $733,437 Federal Grant for Three Therapeutic Development Programs Under Congress’s Therapeutic Discovery Project

TAMPA, Fla.--(BUSINESS WIRE)--Florida-based biopharmaceutical company Oragenics, Inc. (OTCBB: ORNI) (www.oragenics.com) announced that it will receive a $733,437 Federal Grant as part of Congress’s Patient Protection and Affordable Care Act of 2010.